Recurrent ischemic stroke/transient ischemic attack after patent foramen ovale closure: A cohort study
Related Experiment Video
Updated: May 6, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Henrik Sørensen1, Erik L Grove2,3, Johanne Andersen Hojbjerg3,4
1Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Insights
Patent foramen ovale (PFO) closure is recommended for stroke prevention, but recurrent events can occur. Hypertension and hypercoagulable states are linked to recurrent stroke/TIA after PFO closure.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) is linked to ischemic stroke and transient ischemic attack (TIA).
- PFO closure is advised for stroke prevention, yet recurrent stroke risk persists.
- Understanding recurrent stroke causes and complications post-PFO closure is crucial.
Purpose of the Study:
- To investigate the causes of recurrent stroke/TIA after PFO closure.
- To evaluate post-interventional complications in patients undergoing PFO closure.
- To identify risk factors associated with recurrent ischemic events post-PFO closure.
Main Methods:
- Retrospective analysis of 310 patients undergoing PFO closure at Aarhus University Hospital (2018-2023).
- Data collection included demographics, risk factors, procedural details, complications, and recurrent stroke/TIA.
- Median follow-up of 2.6 years.
Main Results:
- Recurrent stroke/TIA occurred in 2.6% of patients (0.98 per 100 patient-years).
- Hypertension (50.0% vs. 16.9%) and hypercoagulable states (62.5%) were associated with recurrent events.
- New-onset atrial fibrillation occurred in 9.4% within 45 days, without subsequent ischemic events.
Conclusions:
- Recurrent ischemic stroke/TIA rates post-PFO closure align with prior studies.
- Pre-existing hypertension and hypercoagulable states are risk factors for recurrent events.
- PFO closure is a viable option, but risk factor management is essential.
Background:
Patent foramen ovale (PFO) has been associated with ischemic stroke and transient ischemic attack (TIA). Guidelines recommend PFO closure for stroke prevention in selected patients, but the risk of recurrent stroke remains high compared to the background population. We aimed to evaluate the causes of recurrent stroke/TIA and post-interventional complications in patients after PFO closure.
Methods:
Patients from the Central Denmark Region who underwent PFO closure at Aarhus University Hospital between November 5, 2018, and May 12, 2023, following an ischemic stroke, TIA, amaurosis fugax, or retinal emboli were included. Data on patient demographics, risk factors, procedural details, post-interventional complications, and recurrent stroke/TIA were collected from electronic medical records.
Results:
PFO closure was performed in 310 patients (median age: 49 years). During a median follow-up of 2.6 years (interquartile range: 1.5-3.6, 814 total patient-years), recurrent stroke/TIA was observed in 8 patients (2.6%), or 0.98 recurrent strokes per 100 patient-years. Recurrent stroke/TIA was more frequent in patients with hypertension (50.0% vs. 16.9%, p = 0.039). Recurrent stroke/TIA was related to thrombophilia or hematologic conditions entailing hypercoagulability in 62.5% of patients. New-onset atrial fibrillation was observed in 9.4% of patients within 45 days after the procedure. None of these patients subsequently developed an ischemic event. Other adverse outcomes were uncommon.
Conclusion:
Rates of recurrent ischemic stroke/TIA after PFO closure were comparable to findings in previous trials. Pre-existing vascular risk factors (hypertension), and a hypercoagulable state were associated with recurrent ischemic stroke/TIA.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

